EurekaMag.com logo
+ Translate

Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication


, : Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication. American Journal of Veterinary Research 50(10): 1672-1677

The antiviral activities of 9-(2-hydroxyethoxymethyl)guanine (acyclovir; ACV) either alone or combined with recombinant human leukocyte (alpha) A/D interferon (rHuIFN-alpha) against feline herpesvirus type 1 (FHV-1) were evaluated in feline embryo cell cultures, using an infectivity-inhibition assay. In ACV-treated cultures, the 50% inhibitory dose (ID50) was approximately 10 to 20 micrograms of ACV/ml. Maximal inhibition of FHV-1 infectivity (range, 3.4 to 4.2 log10 TCID50) was observed when high test doses of ACV (125 or 250 micrograms/ml) were given 1 to 6 hours after infection. Although mild inhibition (range, 0.3 to 1.6 log10 TCID50) of virus was observed at lower drug doses (10 to 62.5 micrograms/ml), FHV-1 was relatively resistant to ACV and required higher minimal inhibitory doses than those reported for other herpesviruses. However, when ACV was combined with 10 or 100 U of rHuIFN-alpha/ml, synergistic antiviral effects were associated with ACV dosage of 10 to 62.5 micrograms/ml. Antiviral activities resulting from use of the combined drugs permitted nearly eightfold reduction in the dose of ACV required to achieve maximal inhibition of FHV-1. Significant (P less than 0.01) synergistic interactions with ACV resulted when the rHuIFN-alpha was given before or after infection; at the lower doses of ACV, however, rHuIFN-alpha pretreatment was more effective. Although dosages of either greater than or equal to 62.5 micrograms of ACV/ml or 100 U of rHuIFN-alpha/ml were cytosuppressive in control cell cultures, additive anticellular effects were not observed at synergistic combinations of ACV and 10 U of rHuIFN-alpha/ml.

(PDF 0-2 workdays service)

Order PDF Full Text

Close
Close

Click here to order any other PDF Full Text


Accession: 001962315

PMID: 2552872

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Siebeck, N.; Hurley, D.J.; Garcia, M.; Greene, C.E.; Köstlin, R.G.; Moore, P.A.; Dietrich, U.M., 2006: Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. Objective - To evaluate the effects of recombinant human interferon alpha -2b (rHuIFN- alpha 2b) and recombinant feline interferon omega (rFeIFN- omega ) on in vitro replication of feline herpesvirus (FHV)-1. Sample Population - Cultures of Crande...

Weiss, R.C.; Toivio-Kinnucan, M., 1988: Inhibition of feline infectious peritonitis virus replication by recombinant human leukocyte (alpha) interferon and feline fibroblastic (beta) interferon. Replication of feline infectious peritonitis virus (FIPV) in feline cell cultures was inhibited after incubation of cells with either human recombinant leukocyte (alpha) interferon (IFN) or feline fibroblastic (beta) IFN for 18 to 24 hours before...

Fulton R.W.; Burge L.J., 1985: Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons. Feline lung monolayer cultures were treated with either a feline interferon (IFN) or one of two recombinant human .alpha.-IFNs and then challenged with feline herpesvirus 1 (FHV-1), feline calicivirus (F-9 strain), or vesicular stomatitis virus. T...

Gomi K.; Kimura H.; Okabe M.; Oka T.; Morimoto M., 1986: Synergistic anticellular and antiviral activities of human recombinant interferon gamma and interferon beta. The synergism of anticellular and antiviral activities of recombinant human interferon-.gamma. (ReIFN-.gamma.) and recombinant human interferon-.beta. (ReIFN-.beta.) was examined in vitro using human melanoma SK-MEL-28 cells. Some differences were...

Gomi, K.; Kimura, H.; Okabe, M.; Oka, T.; Morimoto, M., 1986: Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta. The synergism of anticellular and antiviral activities of recombinant human interferon-gamma (ReIFN-gamma) and recombinant human interferon-beta (ReIFN-beta) was examined in vitro using human melanoma SK-MEL-28 cells. Some differences were detecte...

Campos, M.; Ohmann, H.B.; Hughes, G.; Babiuk, L.A.; Lawman, M.J.P., 1988: Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor rbotnf alpha i. synergistic antiviral efficacy of rbotnf alpha recombinant bovine interferon gamma rbo ifn gamma and their combination. The recent demonstration of the antiviral activity of recombinant human TNF has launched an interest in the use of TNF alpha for antiviral therapy in veterinary medicine. In the precent report, we demonstrate that pretreatment of bovine cells with...

Campos, M.; Ohmann, H.B.; Hughes, G.; Babiuk, L.A.; Lawman, M.J., 1988: Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor (rBoTNF) alpha. I. Synergistic antiviral efficacy of rBoTNF alpha, recombinant bovine interferon gamma (rBoIFN gamma) and their combination. The recent demonstration of the antiviral activity of recombinant human TNF has launched an interest in the use of TNF alpha for antiviral therapy in veterinary medicine. In the precent report, we demonstrate that pretreatment of bovine cells with...

Smith, C.A.; Wigdahl, B.; Rapp, F., 1983: Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus. The efficacy of human alpha interferon (IFN-alpha) combined with 9-(2'-hydroxyethoxymethyl)guanine (acyclovir; ACV), (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-beta-D-arabinofuranosyladenine, or 1-beta-D-arabinofuranosylcytosine on the inhi...

Connell, E.V.; Cerruti, R.L.; Trown, P.W., 1985: Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice. The nucleoside analog acyclovir [9-(2-hydroxyethoxymethyl)guanine] and the hybrid recombinant human alpha interferon (rHuIFN-alpha A/D) were evaluated in weanling mice for their efficacy alone and in combination against a lethal systemic infection...

Vogt, M.W.; Durno, A.G.; Chou, T.C.; Coleman, L.A.; Paradis, T.J.; Schooley, R.T.; Kaplan, J.C.; Hirsch, M.S., 1988: Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1. Effective treatment of infections with human immunodeficiency virus type 1 (HIV-1) may require a combination of antiviral drugs that act by different mechanisms. We report that the combination of 2',3'-dideoxycytidine (ddCyd) and recombi...